Literature DB >> 25193812

Sore eyes and psychosis.

Samantha Colley1, John Smith2.   

Abstract

We present the case of a 30-year-old woman who presented with sexual disinhibition and altered behaviour following an episode of optic neuritis. Her only history was of anxiety disorder. Her differential diagnosis was neurological versus psychiatric. Routine blood tests were unremarkable at this stage. MRI revealed non-specific change and lumbar puncture revealed a slight lymphocytosis and elevated protein and glucose in the cerebrospinal fluid (CSF). PCR on the CSF was negative for viruses: Adenovirus, varicella zoster virus, herpes simplex virus, enterovirus and parechovirus. She was initially treated with intravenous acyclovir to little effect. Antipsychotics olanzapine and haloperidol were also trialled and continued for 3 weeks in total. Once again these medications failed to affect the patient's behaviour but she did begin to show the side effects associated with these medications. Further test results became available at this point-she was anti-N-methyl D-aspartate (NMDA) receptor antibody positive. A diagnosis of anti-NMDA receptor antibody encephalitis was made. The patient was started on cyclophosphamide and methylprednisolone to good effect. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25193812      PMCID: PMC4158209          DOI: 10.1136/bcr-2013-201956

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  NMDA receptor encephalitis mimicking seronegative neuromyelitis optica.

Authors:  M C Kruer; T K Koch; D N Bourdette; D Chabas; E Waubant; S Mueller; M A Moscarello; J Dalmau; R L Woltjer; G Adamus
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

Review 2.  Anti-NMDA-receptor encephalitis: case report and literature review of an under-recognized condition.

Authors:  Gregory S Day; Sasha M High; Bianca Cot; David F Tang-Wai
Journal:  J Gen Intern Med       Date:  2011-02-12       Impact factor: 5.128

Review 3.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Authors:  Josep Dalmau; Eric Lancaster; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

4.  Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.

Authors:  Josep Dalmau; Erdem Tüzün; Hai-yan Wu; Jaime Masjuan; Jeffrey E Rossi; Alfredo Voloschin; Joachim M Baehring; Haruo Shimazaki; Reiji Koide; Dale King; Warren Mason; Lauren H Sansing; Marc A Dichter; Myrna R Rosenfeld; David R Lynch
Journal:  Ann Neurol       Date:  2007-01       Impact factor: 10.422

5.  [Anti-NMDA receptor antibody encephalitis with recurrent optic neuritis and epilepsy].

Authors:  Rie Motoyama; Kazuhiro Shiraishi; Keiko Tanaka; Masako Kinoshita; Masami Tanaka
Journal:  Rinsho Shinkeigaku       Date:  2010-08

6.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

  6 in total
  2 in total

1.  Optic Neuropathy As the Initial Presenting Sign of N-methyl-d-aspartate (NMDA) Encephalitis.

Authors:  Mark Mugavin; Brett H Mueller; Masoom Desai; Karl C Golnik
Journal:  Neuroophthalmology       Date:  2017-01-11

2.  First-episode psychosis in a 15 year-old female with clinical presentation of anti-NMDA receptor encephalitis: a case report and review of the literature.

Authors:  Maria Moura; Amilcar Silva-Dos-Santos; Joana Afonso; Miguel Talina
Journal:  BMC Res Notes       Date:  2016-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.